Insider Trading activities of Polydex Pharmaceuticals Ltd/bahamas insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Polydex Pharmaceuticals Ltd/bahamas since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Polydex Pharmaceuticals Ltd/bahamas since year 2005. Table 2 shows the detailed insider transactions of Polydex Pharmaceuticals Ltd/bahamas since 2005. The reporting company's ticker symbol is POLXF. The reporting company's CIK number is 317158.
The total value of stock buying since 2005 is $67,280.
The total value of stock sales since 2005 is $23,432.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Polydex Pharmaceuticals Ltd/bahamas (POLXF).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-08 27,500 $16,500 0 $0 0 $0
2008-02 17,943 $15,072 0 $0 0 $0
2008-01 14,000 $12,276 0 $0 0 $0
2007-07 13,703 $23,432 13,703 $23,432 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Polydex Pharmaceuticals Ltd/bahamas insiders (POLXF)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-08-25 Usher George G (President and CEO) Buy 27,500 .60 16,500
2008-02-04 Usher George G (President and CEO) Buy 17,943 .84 15,072
2008-01-14 Usher George G (President and CEO) Buy 3,000 .88 2,640
2008-01-10 Usher George G (President and CEO) Buy 11,000 .88 9,636
2007-07-26 Usher George G (President and CEO) Buy 13,703 1.71 23,432
2007-07-26 Estate Of Thomas C Usher (10% Owner) Sale 13,703 1.71 23,432

Insider trading activities including stock purchases, stock sales, and option exercises of POLXF listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Polydex Pharmaceuticals Ltd/bahamas (symbol POLXF, CIK number 317158) see the Securities and Exchange Commission (SEC) website.